You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fampridine

Showing 1 - 25 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Working Memory, Post-covid-19 Trial in Basel (Fampridine SR, Placebo)

Recruiting
  • Working Memory
  • Post-covid-19
  • Fampridine SR
  • Placebo
  • Basel, BS, Switzerland
    University of Basel, Transfaculty Research Platform
Dec 22, 2022

Optic Neuritis Trial in London (Fampridine SR)

Recruiting
  • Optic Neuritis
  • Fampridine SR
  • London, Ontario, Canada
    London Health Sciences Centre
Aug 22, 2022

Working Memory Trial in Basel (Fampridine SR, Placebo)

Recruiting
  • Working Memory
  • Fampridine SR
  • Placebo
  • Basel, BS, Switzerland
    University of Basel, Transfaculty Research Platform
Apr 19, 2022

Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

Completed
Has Results
  • Secondary Progressive Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Fampridine
  • Placebo
  • Dublin, Dublin 4, Ireland
  • +1 more
Jul 8, 2021

Nerve Injury, Prostate Cancer Trial in Rochester (4-Aminopyridine, Placebo)

Recruiting
  • Nerve Injury
  • Prostate Cancer
  • Rochester, New York
  • +1 more
May 13, 2022

Multiple Sclerosis Trial in Odense C (Fampridine)

Completed
  • Multiple Sclerosis
  • Fampridine
  • Odense C, Denmark
    University of Southern Denmark - Odense Univarsity Hospital
Mar 31, 2022

Multiple Sclerosis Trial in Besancon (Fampridine)

Completed
  • Multiple Sclerosis
  • Fampridine
  • Besancon, France
    CHU Jean Minjoz
Jan 29, 2021

Fampridine in Patients With Multiple Sclerosis

Recruiting
  • Multiple Sclerosis
  • cognitive and behavioural questionnaires
  • Madrid, Spain
    Hospital General Universitario Gregorio Marañón
Feb 9, 2021

Working Memory Trial in Basel (Fampridine SR, Placebo)

Withdrawn
  • Working Memory
  • Fampridine SR
  • Placebo
  • Basel, BS, Switzerland
    University of Basel, Transfaculty Research Platform
Oct 13, 2020

Multiple Sclerosis Trial in Cairo (Dalfampridine ER, 10 Mg Oral Tablet, Extended Release, Placebo)

Recruiting
  • Multiple Sclerosis
  • Dalfampridine ER, 10 Mg Oral Tablet, Extended Release
  • Placebo
  • Cairo, Egypt
    Ain Shams Univeristy
Feb 15, 2023

Multiple Sclerosis, Internuclear Ophthalmoplegia Trial in Amsterdam (Clemastine Fumarate, Placebo)

Recruiting
  • Multiple Sclerosis
  • Internuclear Ophthalmoplegia
  • Clemastine Fumarate
  • Placebo
  • Amsterdam, Netherlands
    Amsterdam UMC, location VUmc
Sep 21, 2022

Multiple Sclerosis, Optic Neuritis Trial in Saint Louis (Dalfampridine/Placebo, Placebo/Dalfampridine)

Completed
Has Results
  • Multiple Sclerosis
  • Optic Neuritis
  • Dalfampridine/Placebo
  • Placebo/Dalfampridine
  • Saint Louis, Missouri
    Washington University (John L. Trotter MS Center)
Jan 23, 2020

Central and Peripheral Nervous System Changes as Markers of

Completed
  • Multiple Sclerosis
  • +7 more
    • Sønderborg, Jylland, Denmark
      Department of Neurology (Skleroseklinikken), Sygehus Sønderjylla
    Oct 13, 2021

    Spinal Cord Injury, Muscle Spasticity Trial in Canada, United States (Fampridine-SR, Placebo)

    Completed
    Has Results
    • Spinal Cord Injury
    • Muscle Spasticity
    • Birmingham, Alabama
    • +44 more
    Jan 6, 2020

    Multiple Sclerosis Trial in Gatineau (extended release fampridine, Placebo)

    Completed
    • Multiple Sclerosis
    • extended release fampridine
    • Placebo
    • Gatineau, Quebec, Canada
      Clinique Neuro-Outaouais
    Mar 4, 2019

    Multiple Sclerosis Trial in Berkeley (ketamine)

    Not yet recruiting
    • Multiple Sclerosis
    • Berkeley, California
      Alta Bates Summit Medical Center
    Sep 26, 2023

    Nerve Injury Trial in Hershey (4-Aminopyridine, Placebo oral tablet)

    Terminated
    Has Results
    • Nerve Injury
    • Hershey, Pennsylvania
      MS Hershey Medical Center
    Oct 12, 2022

    Peripheral Nerve Injury, Crush Injury Trial (4-Aminopyridine, Placebo)

    Not yet recruiting
    • Peripheral Nerve Injury
    • Crush Injury
    • (no location specified)
    Aug 18, 2023

    Multiple Sclerosis Trial in Denmark (SR-fampridine, Placebo)

    Completed
    • Multiple Sclerosis
    • Esbjerg, Denmark
    • +3 more
    Aug 22, 2018

    Alemtuzumab Treated Multiple Sclerosis Patients

    Completed
    • Multiple Sclerosis
      • Gatineau, Quebec, Canada
        Clinique Neuro-Outaouais
      Jul 27, 2021

      Spinal Cord Injuries, Chronic Trial in Mexico City (4-Aminopyridine, Placebo oral capsule)

      Active, not recruiting
      • Spinal Cord Injuries
      • Chronic
      • Mexico City, Mexico
        Hospital de Especialidades, CMN Siglo XXI
      Feb 18, 2021

      Episodic Ataxia Type 2 Trial in Los Angeles, Tampa, Rochester (4-Aminopyridine, Placebo)

      Withdrawn
      • Episodic Ataxia Type 2
      • Los Angeles, California
      • +2 more
      Nov 12, 2020

      Individuals With Multiple Sclerosis, With Ataxia Symptoms, No Secondary Disease Affecting Balance Trial in Elazig (Kinesiotape)

      Recruiting
      • Individuals With Multiple Sclerosis
      • +2 more
      • Kinesiotape
      • Elazığ, Turkey
      • +1 more
      Apr 17, 2022

      Multiple Sclerosis Trial in Denmark (Fampridine-SR)

      Completed
      • Multiple Sclerosis
      • Esbjerg, Denmark
      • +3 more
      Aug 22, 2018

      Multiple Sclerosis Trial in Canada, United States (Fampridine-SR, Placebo)

      Completed
      Has Results
      • Multiple Sclerosis
      • Birmingham, Alabama
      • +33 more
      Aug 13, 2018